Literature DB >> 31860218

Response of Lichen Planopilaris to Pioglitazone Hydrochloride

Erik L. Peterson, Daniel Gutierrez, Nooshin K. Brinster, Kristen I. Lo Sicco, Jerry Shapiro.   

Abstract

Lichen planopilaris (LPP) is a cicatricial alopecia that often causes permanent hair loss. Pioglitazone, a peroxisome proliferator activated receptor-gamma (PPAR- γ) agonist, has demonstrated immunomodulatory properties that may offer an effective treatment modality. This retrospective analysis describes 23 patients with LPP treated with adjunctive pioglitazone. Most (18/25) demonstrated significant reduction in patient-reported symptoms and clinical signs of inflammation. No adverse effects were reported. J Drugs Dermatol. 2019;18(12):1276-1279.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31860218

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  3 in total

Review 1.  A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris.

Authors:  Katerina Svigos; Lu Yin; Lauren Fried; Kristen Lo Sicco; Jerry Shapiro
Journal:  Am J Clin Dermatol       Date:  2021-08-04       Impact factor: 7.403

Review 2.  Frontiers in Lichen Planopilaris and Frontal Fibrosing Alopecia Research: Pathobiology Progress and Translational Horizons.

Authors:  Maryanne Makredes Senna; Erik Peterson; Ivan Jozic; Jérémy Chéret; Ralf Paus
Journal:  JID Innov       Date:  2022-03-01

3.  Reversible hair loss in a patient with cicatricial alopecia: A case of regrowth associated with pioglitazone use.

Authors:  Maria Karim; Elizabeth J Klein; Nooshin Brinster; Evan Rieder; Kristen Lo Sicco; Jerry Shapiro
Journal:  JAAD Case Rep       Date:  2022-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.